Yikes, you beat me to it. Some of these are literally 3-4 years old and others offer no new revenue, just extension and defensive signing of existing clients.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025